The U.S. Chamber of Commerce seal is displayed throughout restoration on the headquarters in Washington, D.C.
Andrew Harrer | Bloomberg | Getty Images
The U.S. Chamber of Commerce on Wednesday requested a federal judge in Ohio to block Medicare’s new powers to negotiate drug costs before October 1.
The movement for a preliminary injunction is a big escalation in (*1*) in opposition to Medicare that may halt the talks before they start this fall.
Health and Human Services Secretary Xavier Becerra will publish a list of 10 high-cost medicine by September 1 which can be chosen for the negotiations. Drugmakers then have to determine whether or not to signal agreements to take part within the talks by October 1.
The U.S. Chamber and native chambers of commerce in Dayton, Ohio and Michigan sued Medicare in federal court docket within the southern district of Ohio in June. They argued that the drug negotiations violate the First and Fifth Amendments of the U.S. Constitution, in addition to the separation of powers.
The Chamber requested Judge Thomas Rose on Wednesday to block the negotiations before they get underway as a result of they violate the due course of clause.
Drugmaker Abbvie, a member of the U.S. Chamber and the Dayton, Ohio space chamber, fears that its blood most cancers drug Imbruvica can be chosen for the negotiations this fall. Imbruvica generated $4.6 billion in income final yr, or about 8% of the corporate’s complete gross sales.
This is a growing story. Please verify again for updates.